Ethical issues with genetic testing in pediatrics
- PMID: 11389275
- DOI: 10.1542/peds.107.6.1451
Ethical issues with genetic testing in pediatrics
Abstract
Advances in genetic research promise great strides in the diagnosis and treatment of many childhood diseases. However, emerging genetic technology often enables testing and screening before the development of definitive treatment or preventive measures. In these circumstances, careful consideration must be given to testing and screening of children to ensure that use of this technology promotes the best interest of the child. This statement reviews considerations for the use of genetic technology for newborn screening, carrier testing, and testing for susceptibility to late-onset conditions. Recommendations are made promoting informed participation by parents for newborn screening and limited use of carrier testing and testing for late-onset conditions in the pediatric population. Additional research and education in this developing area of medicine are encouraged.
Similar articles
-
Ethical issues in genetic testing of children.Arch Pediatr Adolesc Med. 2000 Sep;154(9):873-9. doi: 10.1001/archpedi.154.9.873. Arch Pediatr Adolesc Med. 2000. PMID: 10980789 Review. No abstract available.
-
Ethical and policy issues in genetic testing and screening of children.Pediatrics. 2013 Mar;131(3):620-2. doi: 10.1542/peds.2012-3680. Epub 2013 Feb 21. Pediatrics. 2013. PMID: 23428972
-
Ethical, legal, and social concerns about expanded newborn screening: fragile X syndrome as a prototype for emerging issues.Pediatrics. 2008 Mar;121(3):e693-704. doi: 10.1542/peds.2007-0820. Pediatrics. 2008. PMID: 18310190 Review.
-
American Academy of Pediatrics, Committee on Genetics: Issues in newborn screening.Pediatrics. 1992 Feb;89(2):345-9. Pediatrics. 1992. PMID: 1530685 No abstract available.
-
Genetic counseling and neonatal screening for cystic fibrosis: an assessment of the communication process.Pediatrics. 2001 Apr;107(4):699-705. doi: 10.1542/peds.107.4.699. Pediatrics. 2001. PMID: 11335747
Cited by
-
Physicians' perspectives on the uncertainties and implications of chromosomal microarray testing of children and families.Clin Genet. 2013 Jan;83(1):23-30. doi: 10.1111/cge.12004. Epub 2012 Sep 18. Clin Genet. 2013. PMID: 22989118 Free PMC article.
-
Genomic Diagnosis for Pediatric Disorders: Revolution and Evolution.Front Pediatr. 2020 Jul 8;8:373. doi: 10.3389/fped.2020.00373. eCollection 2020. Front Pediatr. 2020. PMID: 32733828 Free PMC article. Review.
-
Management of incidental findings in clinical genomic sequencing.Curr Protoc Hum Genet. 2013;Chapter 9:Unit9.23. doi: 10.1002/0471142905.hg0923s77. Curr Protoc Hum Genet. 2013. PMID: 23595601 Free PMC article.
-
Pharmacogenomic Testing In Pediatrics: Navigating The Ethical, Social, And Legal Challenges.Pharmgenomics Pers Med. 2019 Oct 14;12:273-285. doi: 10.2147/PGPM.S179172. eCollection 2019. Pharmgenomics Pers Med. 2019. PMID: 31686893 Free PMC article.
-
Easing the Burden: Describing the Role of Social, Emotional and Spiritual Support in Research Families with Li-Fraumeni Syndrome.J Genet Couns. 2016 Jun;25(3):529-42. doi: 10.1007/s10897-015-9905-x. Epub 2015 Nov 30. J Genet Couns. 2016. PMID: 26621765